ALK and adenocarcinoma: Echinoderm microtubule‐associated protein‐like 4 and anaplastic lymphoma kinase rearrangement fusion genes (EML4‐ALK) have been previously identified in approximately 5% of NSCLC patients, a population that consists mostly of adenocarcinoma patients.4